Intervention
LY3023414
ClinicalTrials.gov intervention label
Clinical trials
7 shownA Study of LY3039478 in Participants With Advanced or Metastatic Solid TumorsNCT02784795 · 2016-11-04
TERMINATEDA Study of LY3023414 and Necitumumab in Squamous Lung CancerNCT02443337 · 2015-07-01
TERMINATEDA Study of Enzalutamide and LY3023414 in Men With Prostate CancerNCT02407054 · 2015-04-29
COMPLETEDA Study of Prexasertib (LY2606368) With Chemotherapy or Targeted Agents in Participants With Advanced CancerNCT02124148 · 2014-06-18
COMPLETEDA Study of Abemaciclib (LY2835219) in Combination With Another Anti-cancer Drug in Participants With Lung Cancer (NSCLC)NCT02079636 · 2014-03-28
COMPLETEDA Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has SpreadNCT02057133 · 2014-03-10
ACTIVE_NOT_RECRUITINGA Study of LY3023414 in Participants With Advanced CancerNCT01655225 · 2012-07-31
COMPLETEDCommon conditions
Breast Cancer2Advanced Cancer1Breast Neoplasms1Carcinoma, Non-small Cell Lung1Cholangiocarcinoma1Colon Cancer1Colorectal Neoplasms1Malignant Mesothelioma1Metastatic Breast Cancer1Metastatic Cancer1Neoplasm Metastasis1Non-Hodgkin's Lymphoma1Non-small Cell Lung Cancer1Non-small Cell Lung Cancer Metastatic1Prostate Cancer Metastatic1Soft Tissue Sarcoma1Solid Tumor1
Leading sponsors
Trial status mix
COMPLETED4
TERMINATED2
ACTIVE_NOT_RECRUITING1
Phase mix
PHASE15
PHASE22
How to interpret this record
CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.